139 related articles for article (PubMed ID: 10491995)
1. Screening for fatty acid beta oxidation disorders. Acylglycine analysis by electron impact ionization gas chromatography-mass spectrometry.
Kimura M; Yamaguchi S
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):105-10. PubMed ID: 10491995
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
[TBL] [Abstract][Full Text] [Related]
3. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
[TBL] [Abstract][Full Text] [Related]
4. Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency.
Tserng KY; Jin SJ; Kerr DS; Hoppel CL
J Lipid Res; 1990 May; 31(5):763-71. PubMed ID: 2380628
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatography--mass spectrometry (GC--MS) diagnosis of two cases of medium chain acyl-CoA dehydrogenase deficiency.
Divry P; Vianey-Liaud C; Cotte J
J Inherit Metab Dis; 1984; 7 Suppl 1():44-7. PubMed ID: 6434844
[TBL] [Abstract][Full Text] [Related]
6. A study of urinary metabolites in patients with dicarboxylic aciduria for differential diagnosis.
Shimizu N; Yamaguchi S; Orii T
Acta Paediatr Jpn; 1994 Apr; 36(2):139-45. PubMed ID: 8203256
[TBL] [Abstract][Full Text] [Related]
7. Measurement of urinary medium chain acyl glycines by gas chromatography--negative ion chemical ionization mass spectrometry.
Carter SM; Midgley JM; Watson DG; Logan RW
J Pharm Biomed Anal; 1991; 9(10-12):969-75. PubMed ID: 1822221
[TBL] [Abstract][Full Text] [Related]
8. Analysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase deficiency.
Bennett MJ; Coates PM; Hale DE; Millington DS; Pollitt RJ; Rinaldo P; Roe CR; Tanaka K
J Inherit Metab Dis; 1990; 13(5):707-15. PubMed ID: 2246856
[TBL] [Abstract][Full Text] [Related]
9. Acylglycine Analysis by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS).
Hobert JA; Liu A; Pasquali M
Curr Protoc Hum Genet; 2016 Oct; 91():17.25.1-17.25.12. PubMed ID: 27727436
[TBL] [Abstract][Full Text] [Related]
10. Stable isotope dilution analysis of n-hexanoylglycine, 3-phenylpropionylglycine and suberylglycine in human urine using chemical ionization gas chromatography/mass spectrometry selected ion monitoring.
Rinaldo P; O'Shea JJ; Welch RD; Tanaka K
Biomed Environ Mass Spectrom; 1989 Jul; 18(7):471-7. PubMed ID: 2775902
[TBL] [Abstract][Full Text] [Related]
11. C6-C10-dicarboxylic aciduria: biochemical considerations in relation to diagnosis of beta-oxidation defects.
Gregersen N; Kølvraa S; Mortensen PB; Rasmussen K
Scand J Clin Lab Invest Suppl; 1982; 161():15-27. PubMed ID: 6959231
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
[TBL] [Abstract][Full Text] [Related]
13. Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation.
Jones PM; Quinn R; Fennessey PV; Tjoa S; Goodman SI; Fiore S; Burlina AB; Rinaldo P; Boriack RL; Bennett MJ
Clin Chem; 2000 Feb; 46(2):149-55. PubMed ID: 10657369
[TBL] [Abstract][Full Text] [Related]
14. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China.
Jiang M; Liu L; Mei H; Li X; Cheng J; Cai Y
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):375-80. PubMed ID: 25781538
[TBL] [Abstract][Full Text] [Related]
15. Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria.
Gregersen N; Lauritzen R; Rasmussen K
Clin Chim Acta; 1976 Aug; 70(3):417-25. PubMed ID: 947635
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxydicarboxylic and 3-ketodicarboxylic aciduria in three patients: evidence for a new defect in fatty acid oxidation at the level of 3-ketoacyl-CoA thiolase.
Bennett MJ; Sherwood WG
Clin Chem; 1993 May; 39(5):897-901. PubMed ID: 8485884
[TBL] [Abstract][Full Text] [Related]
17. Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders.
Halket JM; Przyborowska A; Stein SE; Mallard WG; Down S; Chalmers RA
Rapid Commun Mass Spectrom; 1999; 13(4):279-84. PubMed ID: 10097403
[TBL] [Abstract][Full Text] [Related]
18. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.
Manning NJ; Olpin SE; Pollitt RJ; Webley J
J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149
[TBL] [Abstract][Full Text] [Related]
19. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
[TBL] [Abstract][Full Text] [Related]
20. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.
Rhead WJ; Amendt BA; Fritchman KS; Felts SJ
Science; 1983 Jul; 221(4605):73-5. PubMed ID: 6857268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
